
Psychosomatics 48:93-102, April 2007
doi: 10.1176/appi.psy.48.2.93
© 2007 Academy of Psychosomatic Medicine
Functional Gastrointestinal Disorders: An Update for the Psychiatrist
Michael P. Jones, M.D.,
Michael D. Crowell, Ph.D.,
Kevin W. Olden, M.D., and
Francis Creed, M.D., F.Med.Sci.
Received February 27, 2006; revised May 8, 2006; accepted June 13, 2006. From the Feinberg School of Medicine, Northwestern University, Chicago, IL; Mayo Clinic College of Medicine, Scottsdale, AZ; Univ. of South Alabama, Mobile, AL; and Manchester Royal Infirmary, Manchester, UK. Send correspondence and reprint requests to Michael P. Jones, M.D., 251 East Huron St., Galter Pavilion 4-104, Chicago, IL 60611-2908. e-mail: mpjones{at}nmh.org
Functional gastrointestinal disorders (FGID) are common conditions, with well-established diagnostic criteria. They are associated with impaired health-related quality of life and increased societal and healthcare costs. Their symptoms are probably related to altered 5-HT transmission and central processing of noxious visceral stimuli. Evaluation and treatment are best formulated using a biopsychosocial model that integrates gut function with psychosocial assessment. Psychological therapies may improve overall well-being and appear to help patients without significant psychiatric comorbidity. Antidepressants help comorbid anxiety and depressive disorders and have primary efficacy in improving the symptoms of FGID. Finally, there is a need for greater involvement of psychiatrists in both the evaluation and treatment of patients with FGID as well as the education and training of practitioners caring for these patients.
Get information about faster international access.
a>
Privacy Policy
Copyright © 2007
Academy of Psychosomatic Medicine.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|